head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing
ISSN: 1312-773X (Online)
Issue: 2017, vol. 23, issue 4
Subject Area: Medicine
DOI: 10.5272/jimab.2017234.1804
Published online: 08 December 2017

Original article

J of IMAB 2017 Oct-Dec;23(4):1804-1807
Tsvetomir DimitrovORCID logo Corresponding Autoremail,
Clinical Department of Ophthalmology, First General Hospital for Active Treatment Sofia AD, Sofia, Bulgaria.

Glaucoma is a disease, which results in definitive vision reduction. The aim of this study is an analysis of the differences in eye impairments in connection with the progression of glaucoma in different age groups (children and adults). A documentary method of investigation of scientific sources, based on clinical practice, is applied. The methodology of the study comprises investigation of causes and manifestations of the disease and its typology. The specific variety in the manifestation of glaucoma is established in children and adults. Excavation of the optic nerve occurs in the adult persons, because the eyeball is already thickened, and collagen is dense. The eye begins to swell in children because the tissues are more loose; the eyeball becomes bigger, and enlargement of cornea and sclera occurs. Children and adults with the diagnosis of glaucoma have a different way of eye impairment. The early establishment and identification of symptoms prevent from the progression of the losses in the visual field, and from blindness, by means of appropriate treatment.

Keywords: glaucoma, children, adults, distinguishing characteristics,

pdf - Download FULL TEXT /PDF 482 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Dimitrov T. Analysis of the variety of eye impairments in glaucoma cases in children and adults. J of IMAB. 2017 Oct-Dec;23(4):1804-1807. DOI: 10.5272/jimab.2017234.1804

Corresponding AutorCorrespondence to: Tsvetomir Dimitrov, Clinical Department of Ophthalmology, First General Hospital for Active Treatment Sofia AD; 37, Patriarch Evtimiy Blvd., Sofia 1000, Bulgaria; E-mail: tsdimitrov.or@gmail.com

1. Schmidt R, Lang F, Heckman M. Phisiologie des Menschen: mit Pathophisiologie. Heidelberg: Springer, 2011.
2. Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol. 2013 Feb;13(1):36-42. [PubMed] [CrossRef]
3. European Glaucoma Society: Terminology and Guidelines for Glaucoma. Savona, Publicomm, 2014, pp 75-127.
4. Izzotti A, Sacca SC, Longobardi M, Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol. 2010 Jun;128(6):724-30. [PubMed] [CrossRef]
5. Erdurmuş M, Yağcı R, Atış Ö, Karadağ R, Akbaş A, Hepşen IF. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res. 2011 Aug;36(8):713-18. [PubMed] [CrossRef]
6. Van de Velde S, De Groef L, Stalmans I, Moons L, Van Hove I: Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics. Prog Neurobiol. 2015 Aug;131:105-119. [PubMed] [CrossRef]
7. Falsini B, Marangoni D, Salgarello T, Stifano G, Montrone L, Di Landro S, et al. Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram. Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1223-33. [PubMed] [CrossRef]
8. Rouland JF, Le Pen C. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year. Eur J Ophthalmol. 2003; 13(Suppl. 4): 5 - 20.
9. Allingham RR, Damji K, Freedman S, Sayoko E, Rhee J, Shields M. et al. Shields’ Textbook of Glaucoma, 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2010.
10. Distelhorst JS, Hughes GM. Open–angle glaucoma. Am Fam Physician. 2003 May;67(9):1937-44. [PubMed]
11. Freeman EE, ;Muñoz B, West SK, Jampel HD, Friedman DS. Glaucoma and quality of life: the Salisbury Eye Evaluation. Ophthalmology. 2008 Feb;115(2):233-8. [PubMed] [CrossRef]
12. Galassi F, Giambene B, Varriale R. Systemic vascular dysregulation and retrobulbar hemodynamics in normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2011 Jun;52(7):4467-71. [PubMed] [CrossRef]
13. Gherghel D, Hosking SL, Armstrong R, Cunliffe IA. Autonomic dysfunction in unselected and untreated primary open angle glaucoma patients: a pilot study. Ophthalmic Physiol Opt. 2007 Jul;27(4):336-41. [PubMed] [CrossRef]
14. Gherghel D, Orgül S, Gugleta K, Flammer J. Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol. 2001 Nov;132(5):641-7. [PubMed] [CrossRef]
15. Hatt S, Wormald R, Burr J. Screening for prevention of optic nerve damage due to chronic open angle glaucoma. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006129. [PubMed] [CrossRef]
16. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):1268-79. [PubMed]
17. Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc. 1998 Jan;46(1):58-64. [PubMed]
18. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007 Nov;114(11):1965-72. [PubMed] [CrossRef]
19. Pache M, Flammer J. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol. 2006 May-Jun;51(3):179-212. [PubMed] [CrossRef]..

Received: 09 September 2017
Published online: 08 December 2017

back to Online Journal